169158 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Sub-classes:Human In Vitro Cardiotoxicity Model
#2METHOD FOR HIGH-THROUGHPUT DETERMINATION OF WHOLE WATER TOXICITY
#3Human In Vitro Cardiotoxicity Model
#4METHOD FOR DETERMINATION OF WHOLE WASTEWATE TOXICITY
#5METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE
#6METHODS AND PRODUCTS FOR EXPRESSING PROTEINS IN CELLS
#7DERIVATION OF HUMAN MICROGLIA FROM PLURIPOTENT STEM CELLS
#8PEPTIDE-BASED DELIVERY AGENT AND METHOD OF MAKING AND USING THE SAME
#9IN VITRO CONSTRUCT USEFUL FOR DRUG TOXICITY SCREENING
#10INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND PROGRAM
#11METHOD FOR CHARACTERIZING, TYPING AND IDENTIFYING CELLS AND USE THEREOF
#12INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND PROGRAM
#13OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION
#14METHOD FOR THE CHARACTERIZATION OF PRODUCTS FOR CELL THERAPY
#15NON-RADIOACTIVE CYTOTOXICITY ASSAYS
#16METHODS AND APPARATUSES FOR TESTING HEPATOCYTE TOXICITY USING MICROORGANOSPHERES
#17CENTRIFUGAL IMPACT-BASED BIOAEROSOL ENRICHMENT DEVICE, AND CELL EXPOSURE AND USE THEREOF
#18ANTIPARASITIC AGENTS AND METHODS
#19METHOD FOR CONSTRUCTING HEPATIC PROGENITOR CELL-LIKE CELL BANK, CELL LINES PREPARED THEREFROM AND APPLICATION THEREOF
#20PLACENTA ORGANOID ON-A-CHIP AND USE THEREOF
#21IN VITRO ASSAY TO PREDICT CARDIOTOXICITY
#22EX VIVO SYSTEMS AND METHODS FOR DETERMINING THE EFFECT OF A DRUG OR OTHER AGENT ON A TISSUE
#23METHODS TO GENERATE POLYMER SCAFFOLDS HAVING A GRADIENT OF CROSSLINKING DENSITY
#24COMPLEMENT-DEPENDENT CYTOTOXICITY METHODS
#25DUAL GENETIC REPORTERS IN HUMAN PLURIPOTENT CELLS FOR USE AS ALTERNATIVE TO MOUSE EMBRYO ASSAY
#26RESPIRATORY ORGANOIDS WITH EXTERNALLY ATTACHED CILIATED EPITHELIAL CELLS AND METHOD FOR PREPARING THE SAME
#27ENGINEERING OF MULTIFUNCTIONAL PEPTIDES FOR CONTROLLED DRUG DELIVERY
#28THERAPEUTIC MEDICATION/PREVENTATIVE MEDICATION TARGETING SENESCENT CELLS OR SASP, METHOD FOR ACQUIRING DATA FOR DETECTING SENESCENT CELLS, AND SCREENING METHOD FOR THERAPEUTIC MEDICATION/PREVENTATIVE MEDICATION
#29COMPOSITIONS AND METHODS FOR DETECTING CARDIOTOXICITY
#30NEXT GENERATION DESIGNER LIVER ORGANOIDS AND THEIR METHODS OF PREPARATION AND USE
#31HUMAN FATTY-LIVER MODEL CELLS
#32Human Homogeneous Amniotic Fluid Stem Cell Lines And Uses Thereof
#33MULTI-DEPTH SPIRAL MILLI FLUIDIC DEVICE FOR WHOLE MOUNT ZEBRAFISH ANTIBODY STAINING
#34GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC NKP46
#35HUMAN LIVER-LIKE THREE-DIMENSIONAL STRUCTURE, METHOD FOR EVALUATING HEPATOTOXICITY AND HUMAN LIVER-LIKE COMPLEX
#36OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION
#37SYSTEMS AND METHODS FOR IDENTIFYING BIOACTIVE AGENTS UTILIZING UNBIASED MACHINE LEARNING
#38METHODS AND RELATED ASPECTS OF QUANTIFYING PROTEIN STABILITY AND MISFOLDING
#39METHOD FOR DETERMINING ACUTE TOXICITY AND A SYSTEM USING SAID METHOD
#40H3.3 CTL PEPTIDES AND USES THEREOF
#41CELL-BASED METHOD FOR DETERMINING AN ACTIVITY OF BOTULINUM TOXIN
#42CYTOTOXICITY ASSAY FOR DETECTING CELLULAR DAMAGE
#43Organoid Compositions
#44MATERIALS AND METHODS FOR PREVENTING OR REDUCING TOXICITY TO ORGANOPHOSPHATES AND OTHER TOXIC MATERIALS
#45HEPATOCYTES AND HEPATIC NON-PARENCHYMAL CELLS, AND METHODS FOR PREPARATION THEREOF
#46IMAGING-BASED DROPLET DRUG ASSAYS
#47SENOLYTIC DRUG SCREENING METHOD AND SENOLYTIC DRUG
#48LOW AFFINITY FcyR DEFICIENT MICE
#49GENERATING ATRIAL AND VENTRICULAR CARDIOMYOCYTE LINEAGES FROM HUMAN PLURIPOTENT STEM CELLS
#50COMPOSITIONS COMPRISING A ZIM3 EFFECTOR AND METHODS OF USE THEREOF
#51LABEL FREE DRUG AND TISSUE BIOPSY SCREENING/DIAGNOSTIC IN CANCER
#52Renal Progenitor Cells
#53IMPROVED METHODS FOR IDENTIFICATION OF FUNCTIONAL CELL STATES
#54HUMAN CEREBELLAR ORGANOIDS WITH BONA FIDE PURKINJE CELLS AND USES THEREOF
#55CULTURE MEDIUM COMPOSITION AND METHOD OF CULTURING CELL OR TISSUE USING THEREOF
#56IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
#57Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells
#58TREATMENT METHODS HAVING REDUCED DRUG-RELATED TOXICITY AND METHODS OF IDENTIFYING THE LIKELIHOOD OF PATIENT HARM FROM PRESCRIBED MEDICATIONS
#59NOVEL NEURONAL CELL LINE FOR MEASURING TITER OF NEUROTOXIN
#60MULTIPLEX GENOME ENGINEERING IN EUKARYOTES
#61Droplet imaging pipeline
#62METHODS TO PREVENT TERATOGENICITY OF IMID LIKE MOLECULES AND IMID BASED DEGRADERS/PROTACS
#63NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE
#64METHOD FOR EVALUATING DRUG TOXICITY
#65MATERIALS AND METHODS TO IMPROVE IN VITRO TOXICITY PREDICTIONS
#66Method for establishing biological model on joint toxicity of Caenorhabditis elegans and application thereof
#67OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION
#68CELL-BASED METHOD FOR DETERMINING AN ACTIVITY OF BOTULINUM TOXIN
#69Droplet imaging pipeline
#70MICROFLUIDIC PROXIMIAL TUBULE KIDNEY-ON-CHIP
#71METHODS TO GENERATE POLYMER SCAFFOLDS HAVING A GRADIENT OF CROSSLINKING DENSITY
#72TISSUE-MIMICKING HYDROGEL COMPOSITIONS FOR BIOFABRICATION
#73Mass Spectrometric Determination of Cell Toxicity
#74METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE
#75SYSTEMS AND METHODS FOR PREDICTING CARDIOTOXICITY OF MOLECULAR PARAMETERS OF A COMPOUND BASED ON MACHINE LEARNING ALGORITHMS
#76COMPOSITIONS AND METHODS OF CELL ATTACHMENT
#77CELLS USEFUL FOR IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#78IN VITRO NEPHROTOXICITY SCREENING ASSAY
#79Oligonucleotides for inducing paternal UBE3A expression
#80METHODS OF INCREASING MATURATION OF HEART, PANCREATIC BETA-CELLS, AND NEURONS
#81Method for producing retinal pigment epithelial cells
#82IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#83SYNTHESIS AND USE OF N-BENZYL SULFONAMIDES
#843D Tissue Culture Materials and Processes for Producing Same
#85IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#86HLA-F-modified cells and methods
#87System and methods for multiplexed analysis of cellular and other immunotherapeutics
#88CELLULAR-BASED METHOD FOR DETERMINING THE POTENCY OF DEFIBROTIDE
#89ASSAY FOR DRUG DISCOVERY BASED ON IN VITRO DIFFERENTIATED CELLS
#90MULTI-LINEAGE CARDIOVASCULAR MICROFLUIDIC ORGAN-CHIP
#91BIOMIMETIC HEART TISSUE CULTURE SYSTEM
#92ENCAPSULATED LIVER TISSUE
#93Analytical Assessment Of Bacterial Endotoxin
#94FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE
#95Engineered Cytolytic Immunecell
#96METHOD AND REAGENTS TO IMPROVE NONANIMAL OCULAR TOXICITY TESTS
#97METHODS RELATED TO TOXICITY AND RESPONSE ASSOCIATED WITH CELL THERAPY FOR TREATING B CELL MALIGNANCIES
#98HLA-F-MODIFIED CELLS AND METHODS
#99GENERATION OF MATURE KUPFFER CELLS
#100CHARACTERISTIC ANALYSIS METHOD AND CLASSIFICATION OF PHARMACEUTICAL COMPONENTS BY USING TRANSCRIPTOMES
#101BIOMIMETIC NERVE CHIP FOR EVALUATING EFFICACY AND TOXICITY ON NERVE, AND USE THEREOF
#102METHODS FOR ASSESSING TOXICITY OF A COMPOUND
#103METHODS FOR SCREENING CEREBLON MODIFYING COMPOUNDS
#104IN VITRO DRUG METABOLISM REAGENT AND USES THEREOF
#105METHOD FOR CONSTRUCTING HEPATIC PROGENITOR CELL-LIKE CELL BANK, CELL LINES PREPARED THEREFROM AND APPLICATION THEREOF
#106METHODS FOR EVALUATING SUITABILITY OF A BIOCHEMICAL FILTER
#107ENGINEERING SPATIAL-ORGANIZED CARDIAC ORGANOIDS FOR DEVELOPMENTAL TOXICITY TESTING
#108Cells Highly Sensitive to Clostridial Neurotoxin
#109Ex vivo systems and methods for determining the effect of a drug or other agent on a tissue
#110Human liver-like three-dimensional structure, method for evaluating hepatotoxicity and human liver-like complex
#111Methods for Improving Cell Viability In A Production BioReactor
#112Single-cell-based Electrochemical Sensor based on Functionalized Nano-probe and Application thereof
#113CULTURE MEDIUM COMPOSITION AND METHOD OF CULTURING CELL OR TISSUE USING THEREOF
#114METHODS OF MEASURING CELL-MEDIATED KILLING BY EFFECTORS
#115ATRIAL CARDIAC MICROTISSUES FOR CHAMBER-SPECIFIC ARRHYTHMOGENIC TOXICITY RESPONSES
#116BACILLUS THURINGIENSIS TOXIN RECEPTORS AND USES THEREOF
#117Non-radioactive cytotoxicity assays
#118SCREENING METHOD AND TOXICITY EVALUATION METHOD
#119METHODS AND PRODUCTS FOR EXPRESSING PROTEINS IN CELLS
#120Diagnosis method and diagnosis device of ecotoxicity of solid waste soil in pesticide production site
#121Method To Evaluate Metabolic Activity Of Liver Enzymes
#122Methods for screening host cells expressing target proteins
#123MOUSE MODEL FOR ASSESSING TOXICITIES ASSOCIATED WITH IMMUNOTHERAPIES
#124SMALL MOLECULE SCREENING CELLULAR ASSAY USING MODIFIED BEADS
#125CULTURE APPARATUS FOR DRUG DISCOVERY RESEARCH
#126A HUMAN IN VITRO CARDIOTOXICITY MODEL
#127In Vitro Cell-Based Replacement for the Draize Test
#128Ex vivo systems and methods for determining the effect of a drug or other agent on a tissue
#129PHYSIOLOGIC GROWTH OF CULTURED INTESTINAL TISSUE
#130HUMAN FATTY-LIVER MODEL CELLS
#131METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE
#132HUMAN IN VITRO CARDIOTOXICITY MODEL
#133COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITING
#134ULTRASENSITIVE METHOD FOR DETECTING CELL DEATH
#135Oligonucleotides for inducing paternal UBE3A expression
#136IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#137Device for measuring hair exposure to pollutants or proximity to pollutant sources and recommending personalized haircare products
#138Device for measuring hair exposure to harmful light and recommending personalized haircare products
#139MICROARRAY COMPOSITIONS AND METHODS OF THEIR USE
#140Production method for retinal tissue
#141H3.3 CTL PEPTIDES AND USES THEREOF
#142VASCULARIZED ORGANOID MODEL INCORPORATING ISOLATED HUMAN MICROVESSEL FRAGMENTS
#143USE OF NEUROPILIN-1 (NRP1) AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
#144PRODUCTION METHOD FOR NERVE TISSUE
#145VITRO ASSAY FOR DRUG DISCOVERY OF VALVULAR HEART DISEASE
#146Multi-compartment device containing human three-dimensional (3D) microtissues for toxicity testing
#147USE OF BIOMARKERS TO EVALUATE THE EFFICACY OF A COMPOSITION IN REDUCING THE EFFECTS OF CANCER THERAPEUTICS ON SKIN
#148Microfluidic proximal tubule kidney-on-chip
#149METHODS OF GENERATING ORGANOIDS FOR HIGH THROUGHPUT SCREENING OF DRUGS
#150CARDIOTOXICITY ASSESSMENT METHOD
#151Method for preparing intestinal tract cell layer derived from pluripotent stem cell
#152DERIVATION OF HUMAN MICROGLIA FROM PLURIPOTENT STEM CELLS
#153Bioreactor System
#154Compositions and methods for regulating glucose homeostasis and insulin action
#155CELL-BASED METHOD FOR DETERMINING AN ACTIVITY OF BOTULINUM TOXIN
#156METHOD FOR ESTIMATING SURVIVAL OF COLCHICINE-INTOXICATED PATIENTS
#157IN VITRO NEPHROTOXICITY SCREENING ASSAY
#158METHOD FOR EVALUATING THE PRESENCE OF A VIRAL RESERVOIR, AND EVALUATING THE EFFICACY OF A DRUG AGAINST SAID RESERVOIR
#159Method for Producing Stem/Precursor Cells, By Using Low Molecular Weight Compound, From Cells Derived From Endodermal Tissue or Organ
#1603D HUMAN CANCER MODEL-BASED COMBINATORIAL DRUG DEVELOPMENT METHOD
#161ORGANOID PRODUCED USING CARRIER FOR CELL CULTURE, AND METHOLD FOR EVALUATING DRUG TOXICITY USING SAME
#162IDENTIFICATION AND USE OF CYTOTOXIC T LYMPHOCYTE (CTL) ANTIGEN-SPECIFIC TARGET CELL KILLING ENHANCER AGENTS
#163INTEGRATED DRUG DISCOVERY PLATFORM FOR INBORN ERROR OF METABOLISM DISORDERS
#164Systems and methods for identifying bioactive agents utilizing unbiased machine learning
#165Renal progenitor cells
#166METHODS AND COMPOSITIONS FOR DETECTION AND VISUALIZATION OF OXIDATIVE STRESS-INDUCED CARBONYLATION IN CELLS
#167IN VITRO TOXICITY SCREENING ASSAY
#168METHODS FOR ASSAYING BIOLOGICAL CELLS IN A MICROFLUIDIC DEVICE
#169Methods of using humanized FCγR mice to assay Fc regions
#170Immuno-based botulinum toxin serotype A activity assays
#171METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS
#172USE OF AN EGG GRAFTED WITH TUMOR CELLS IN ORDER TO STUDY THE ANTI-CANCER EFFECTIVENESS OF IMMUNE THERAPIES IN THE ABSENCE OF IMMUNE EFFECTOR CELLS OTHER THAN THOSE IN THE GRAFTED EGG
#173Methods for Identifying Two or More Populations Having Different Responses to Chemical or Biological Agents
#174SYSTEM AND METHODS FOR IDENTIFYING CANCER CELL LINES HAVING ANTI-GROWTH ACTIVITY AGAINST OTHER CANCER CELL LINES
#175Cell culture
#176COMPOSITIONS AND METHODS FOR ASSESSING TOXICITY USING DYNAMIC BH3 PROFILING
#177GDF-15 AS A HAEMATOLOGICAL TOXICITY BIOMARKER
#178Next generation designer liver organoids and their methods of preparation and use
#179GDF-15 AS A HAEMATOLOGICAL TOXICITY BIOMARKER
#180Method for preparing PHFS-like Tau aggregates
#181Multiplex genome engineering in eukaryotes
#182LUX EXPRESSION IN CELLS AND METHODS OF USE
#183Engineered renal tissues, arrays thereof, and methods of making the same
#184METHODS OF CULTURING PODOCYTES AND COMPOSITIONS THEREOF
#185MICROELECTRODE ARRAY AND USES THEREOF
#186PLANT-DERIVED NANOFIBRILLAR CELLULOSE HYDROGEL FOR CELL CULTURE AND CHEMICAL TESTING
#187Living biosensors
#188Method for evaluating the efficacy of a composition in reducing the effects of cancer therapeutics on skin
#189IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
#190CELLS USEFUL FOR IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#191Mouse having a humanized cluster of differentiation 47 gene
#192IN VITRO METHOD FOR PROVIDING STEM CELL DERIVED CARDIOMYOCYTES
#193BLOOD BRAIN BARRIER MODELS AND METHODS TO GENERATE AND USE THE SAME
#194Treatment methods having reduced drug-related toxicity and methods of identifying the likelihood of patient harm from prescribed medications
#195Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations
#196Perfusion plate for microarray 3D bioprinting
#197Means and methods for the determination of the biological activity of BoNT/E in cells
#198IN VITRO ASSAY TO PREDICT CARDIOTOXICITY
#199GENE EXPRESSION AND ASSESSMENT OF RISK OF DEVELOPING TOXICITY FOLLOWING CELL THERAPY
#200Cell-based method for determining an activity of botulinum toxin
#201High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cells
#202H3.3 CTL peptides and uses thereof
#203ENGINEERED CYTOLYTIC IMMUNECELL
#204Non-invasive, in vitro functional tissue assay systems
#205Cell electrochemical sensor based on 3D printing technology and application thereof
#206COMPONENT ANALYSIS DEVICE, DRUG COMPONENT ANALYSIS DEVICE, COMPONENT ANALYSIS METHOD, AND DRUG COMPONENT ANALYSIS METHOD
#207Compositions and methods for improving sensitivity in cell based assays
#208TUMOR MINIMAL RESIDUAL DISEASE STRATIFICATION
#209COMPOSITIONS AND METHODS FOR EVALUATING ATTENUATION AND INFECTIVITY OF LISTERIA STRAINS
#210Carbopyronone Compounds Useful as Diagnostic Adjuvants
#211Biocompatible and bioabsorbable derivatized chitosan compositions
#212BIOLUMINESCENT SCREENING TEST FOR DETECTING CELL CYTOLYSIS
#213Methods of treating and preventing infections and associated conditions
#214NOVEL SCREENING METHOD FOR TGF-BETA INHIBITOR
#215Lux expression in cells and methods of use
#216Skin barrier preparation and method therefor
#217Methods for the design of mechanism-based sirtuin activating compounds
#218Placental lipid bilayer for cell-free molecular interaction studies
#219IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#220Compositions and methods for regulating glucose homeostasis and insulin action
#221PLATFORM FOR EARLY DETECTION OF PATHOGEN INFECTION
#222Oligonucleotides for inducing paternal UBE3A expression
#223METHODS TO PREVENT TERATOGENICITY OF IMID LIKE MOLECULES AND IMID BASED DEGRADERS/PROTACS
#224METHODS AND SYSTEM OF HUMAN HEMOGENIC REPROGRAMING
#225Cell-based method for determining an activity of botulinum toxin
#226Cell-based method for determining an activity of botulinum toxin
#227Silicon-rhodamine fluorescent probe containing hydrophobic group and use thereof
#228Cell-based method for determining an activity of botulinum toxin
#229Methods and products for expressing proteins in cells
#230HIGH-THROUGHPUT IMAGING-BASED METHODS FOR PREDICTING CELL-TYPE-SPECIFIC TOXICITY OF XENOBIOTICS WITH DIVERSE CHEMICAL STRUCTURES
#231Cell-based assay using electrophysiological activity measured with microelectrode arrays
#232Kidney organoids and methods of manufacturing
#233Test method for toxicity of raw dinotefuran drug on early life stage of fish
#234TEST METHOD OF COMBINED TOXICITY FOR CHLORPYRIFOS AND BUTACHLOR
#235Organoid and method for producing same
#236Device, system, and kit for measuring tension of cell structure containing muscle cells
#237Microfluidic proximal tubule kidney-on-chip
#238USE OF LIFR OR FGFR3 AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
#239ANALYTICAL PROCESS FOR GENOTOXICITY ASSESSMENT
#240Methods for differentiating cells into hepatic stellate cells
#241Identification of subpopulations of cardiomyocytes
#242Method for screening, isolating and purifying analytes
#243COMPOSITIONS AND METHODS FOR DETECTING CARDIOTOXICITY
#244Culture medium composition and method of culturing cell or tissue using thereof
#245Microtissue compartment device
#246Cell aggregate including retinal tissue and production method therefor
#247Hepatocytes and hepatic non-parenchymal cells, and methods for preparation thereof
#248Cell-based method for determining an activity of botulinum toxin
#249Method for assisting prediction of risk of occurrence of side effect of irinotecan
#250SYSTEM AND METHODS FOR MULTIPLEXED ANALYSIS OF CELLULAR AND OTHER IMMUNOTHERAPEUTICS
#251METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE
#252METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE
#253Methods for isolating human cardiac ventricular progenitor cells
#254FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE
#255Modulation of complement-dependent cytotoxicity through modifications of the C-terminus of antibody heavy chains
#256In vitro nephrotoxicity screening assay
#257H3.3 CTL peptides and uses thereof
#258Human homogeneous amniotic fluid stem cell lines and uses thereof
#259Dynamic BH3 profiling
#260Transgenic biosensor
#261Humanized low affinity FCγR mouse cells
#262Oligonucleotides for inducing paternal UBE3A expression
#263CELLULAR-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE
#264Systems and methods for monitoring immunotherapy toxicity
#265Methods and products for expressing proteins in cells
#266ENZYME-LINKED ASSAY FOR MEASUREMENT OF PORPHOBILINOGEN (PBG)
#267Methods and products for expressing proteins in cells
#268Methods and products for expressing proteins in cells
#269Methods and products for expressing proteins in cells
#270DEVICE FOR EVALUATION OF CHEMICAL SUBSTANCE AND METHOD FOR EVALUATION OF CHEMICAL SUBSTANCE
#271Methods and products for expressing proteins in cells
#272Methods and products for expressing proteins in cells
#273Methods and products for expressing proteins in cells
#274Methods and products for expressing proteins in cells
#275Methods and products for expressing proteins in cells
#276HYDROGEL COMPOSITIONS FOR USE IN NEURAL CELL EXPANSION AND DIFFERENTIATION
#277Microarray compositions and methods of their use
#278Detection analyzer
#279H3.3 CTL peptides and uses thereof
#280IN-VITRO METHODS FOR CLASSIFYING DRUGS ACCORDING TO THEIR POTENTIAL TO CAUSE LIVER CELL INJURY
#281METHOD OF IDENTIFYING AGENTS THAT AFFECT MATURATION, SURVIVAL AND MYELINATION
#282Maintenance culture of induced pluripotent stem cell-derived intestinal stem cells
#283Real-time cell-surface marker detection
#284Methods of selecting therapeutic molecules
#285Ex vivo antigen and adjuvant pulsed peripheral blood mononuclear cells as a screening platform for candidate novel vaccines and candidate antigens
#286APPARATUS AND METHODS FOR IN VITRO PRECLINICAL HUMAN TRIALS
#287HUMAN CARDIAC TISSUE CONSTRUCT, RELATED METHODS AND USES
#288Methods and products for expressing proteins in cells
#289Methods for evaluating suitability of a biochemical filter
#290GENERATING ATRIAL AND VENTRICULAR CARDIOMYOCYTE LINEAGES FROM HUMAN PLURIPOTENT STEM CELLS
#291Compositions and methods for improving sensitivity in cell based assays
#292Material for screening for compound acting on ION channel and use thereof
#293Compositions and methods of regulating glucose homeostasis and insulin action
#294CHARACTERISTIC ANALYSIS METHOD AND CLASSIFICATION OF PHARMACEUTICAL COMPONENTS BY USING TRANSCRIPTOMES
#295Immuno-based retargeted endopeptidase activity assays
#296System and products for improved quantification of ADCC activity
#297Oligonucleotides for inducing paternal UBE3A expression
#298Engineered potent cytotoxic stapled BH3 peptides
#299METHOD FOR PREPARING LIVER PROGENITOR CELLS
#300Metabolically competent cells, methods of making, and uses thereof